Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cosford

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
Journal of Medicinal Chemistry|December 16, 2010
Design and synthesis of an orally active metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulator (PAM) that decreases cocaine self-administration in ratsRaveendra-Panickar Dhanya, Shyama Sidique, Douglas J Sheffler, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 22, 2025
Spontaneous daily sleep disruptions associated with morphine dependence and withdrawal in ratsHarlie A McKelvey, Bethany E Pierce, Jesse M Lynch, et al.
Journal of Medicinal Chemistry|September 3, 2004
Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activityJeffrey Roppe, Nicholas D Smith, Dehua Huang, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2014
Design, synthesis and evaluation of benzoisothiazolones as selective inhibitors of PHOSPHO1Yalda Bravo, Peter Teriete, Raveendra-Panickar Dhanya, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2013
Design, synthesis and evaluation of inhibitor of apoptosis protein (IAP) antagonists that are highly selective for the BIR2 domain of XIAPRobert J Ardecky, Kate Welsh, Darren Finlay, et al.
Journal of Medicinal Chemistry|March 4, 2015
Perturbation of the c-Myc-Max protein-protein interaction via synthetic α-helix mimeticsKwan-Young Jung, Huabo Wang, Peter Teriete, et al.
Journal of Biomolecular Screening|August 13, 2015
Cell-Based High-Throughput Luciferase Reporter Gene Assays for Identifying and Profiling Chemical Modulators of Endoplasmic Reticulum Signaling Protein, IRE1Juan Rong, Ian Pass, Paul W Diaz, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2011
Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAPMarcos González-López, Kate Welsh, Darren Finlay, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3'-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activityJeffrey R Roppe, Bowei Wang, Dehua Huang, et al.
Molecular Cancer Therapeutics|November 7, 2013
Small-molecule IAP antagonists sensitize cancer cells to TRAIL-induced apoptosis: roles of XIAP and cIAPsDarren Finlay, Mitchell Vamos, Marcos González-López, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Journal of Medicinal Chemistry|December 16, 2010
Design and synthesis of an orally active metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulator (PAM) that decreases cocaine self-administration in ratsRaveendra-Panickar Dhanya, Shyama Sidique, Douglas J Sheffler, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 22, 2025
Spontaneous daily sleep disruptions associated with morphine dependence and withdrawal in ratsHarlie A McKelvey, Bethany E Pierce, Jesse M Lynch, et al.
Journal of Medicinal Chemistry|September 3, 2004
Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activityJeffrey Roppe, Nicholas D Smith, Dehua Huang, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2014
Design, synthesis and evaluation of benzoisothiazolones as selective inhibitors of PHOSPHO1Yalda Bravo, Peter Teriete, Raveendra-Panickar Dhanya, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2013
Design, synthesis and evaluation of inhibitor of apoptosis protein (IAP) antagonists that are highly selective for the BIR2 domain of XIAPRobert J Ardecky, Kate Welsh, Darren Finlay, et al.
Journal of Medicinal Chemistry|March 4, 2015
Perturbation of the c-Myc-Max protein-protein interaction via synthetic α-helix mimeticsKwan-Young Jung, Huabo Wang, Peter Teriete, et al.
Journal of Biomolecular Screening|August 13, 2015
Cell-Based High-Throughput Luciferase Reporter Gene Assays for Identifying and Profiling Chemical Modulators of Endoplasmic Reticulum Signaling Protein, IRE1Juan Rong, Ian Pass, Paul W Diaz, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2011
Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAPMarcos González-López, Kate Welsh, Darren Finlay, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3'-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activityJeffrey R Roppe, Bowei Wang, Dehua Huang, et al.
Molecular Cancer Therapeutics|November 7, 2013
Small-molecule IAP antagonists sensitize cancer cells to TRAIL-induced apoptosis: roles of XIAP and cIAPsDarren Finlay, Mitchell Vamos, Marcos González-López, et al.
Pageof 11